Topic: Introducing Shield

May 2, 2022

Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults

Highly sensitive Shield test offers convenient screening method that can be completed with simple blood draw……

Read More…

Guardant Health Announces Colorectal Cancer Blood Test for Average-Risk Adults

Today, precision oncology company Guardant Health announced the availability of Shield, a blood-based test for the detection of early-stage colorectal cancer (CRC)…….

Read More…